Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model. https://t.co/FsdnvPWQej
Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model. https://t.co/MVdoHDVi5H
Published this week in @BMCMedicine: Informing decision-making for universal access to quality #tuberculosis diagnosis in #India: an economic-epidemiological model https://t.co/EkIVHGBFXS @JohnsHopkinsSPH https://t.co/0LAPffOy3B
RT @BMCMedicine: NEW: Research from @paimadhu et al: Decentralization of Xpert testing for #tuberculosis is likely to be cost-saving or cos…
RT @BMCMedicine: NEW: Research from @paimadhu et al: Decentralization of Xpert testing for #tuberculosis is likely to be cost-saving or cos…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @BMCMedicine: NEW: Research from @paimadhu et al: Decentralization of Xpert testing for #tuberculosis is likely to be cost-saving or cos…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @BMCMedicine: NEW: Research from @paimadhu et al: Decentralization of Xpert testing for #tuberculosis is likely to be cost-saving or cos…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @BMCMedicine: NEW: Research from @paimadhu et al: Decentralization of Xpert testing for #tuberculosis is likely to be cost-saving or cos…
NEW: Research from @paimadhu et al: Decentralization of Xpert testing for #tuberculosis is likely to be cost-saving or cost-effective in most settings https://t.co/yQokR5IM9F @StopTB @TBAlliance @LSHTM_TB
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
RT @paimadhu: Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #t…
Should India decentralize TB molecular testing? This epi-econ model might help! https://t.co/9Uf6KSyE9J via @BioMedCentral #tuberculosis https://t.co/BL6LUOsv2x